382 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Harel Insurance Investments & Financial Services Ltd.

Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 382 shares of the company’s stock, valued at approximately $115,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MML Investors Services LLC boosted its holdings in shares of HCA Healthcare by 31.7% during the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after buying an additional 4,285 shares during the period. Meritage Group LP acquired a new stake in shares of HCA Healthcare in the third quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $18,044,000. Alpha DNA Investment Management LLC bought a new position in HCA Healthcare in the 3rd quarter worth approximately $869,000. Finally, NRI Wealth Management LC bought a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $2,896,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of several research analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Barclays cut their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. TD Cowen lowered their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Morgan Stanley lowered their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Price Performance

Shares of HCA stock opened at $312.51 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock has a market capitalization of $79.16 billion, a PE ratio of 14.03, a PEG ratio of 1.09 and a beta of 1.64. HCA Healthcare, Inc. has a 52 week low of $279.93 and a 52 week high of $417.14. The stock’s fifty day moving average is $313.49 and its 200-day moving average is $352.62.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same period last year, the company earned $5.90 earnings per share. Equities research analysts expect that HCA Healthcare, Inc. will post 21.75 EPS for the current fiscal year.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.